English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  51499070    Online Users :  771
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"jia horng kao"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 656-680 of 1180  (48 Page(s) Totally)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T05:16:37Z HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:37Z Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment Liu C.-H.; Yang S.-S.; Peng C.-Y.; Lin W.-T.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:36Z 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.
臺大學術典藏 2021-09-04T05:16:36Z Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence Lin C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:35Z Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply Estes C.; Chan H.L.Y.; Chien R.N.; Chuang W.-L.; Fung J.; Goh G.B.-B.; Hu T.H.; Huang J.-F.; Jang B.K.; Jun D.W.; JIA-HORNG KAO; Lee J.-W.; Lin H.-C.; Razavi-Shearer K.; Seto W.-K.; Wong G.L.H.; Wong V.W.S.; Razavi H.
臺大學術典藏 2021-09-04T05:16:35Z Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing Yang Y.-C.; Chen Y.-H.; JIA-HORNG KAO; Ching C.; Liu I.-J.; Wang C.-C.; Tsai C.-H.; Wu F.-Y.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Yang H.-C.
臺大學術典藏 2021-09-04T05:16:35Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:34Z 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations Yu M.-L.; Chen P.-J.; Dai C.-Y.; Hu T.-H.; Huang C.-F.; Huang Y.-H.; Hung C.-H.; Lin C.-Y.; Liu C.-H.; Liu C.-J.; Peng C.-Y.; Lin H.-C.; JIA-HORNG KAO; Chuang W.-L.
臺大學術典藏 2021-09-04T05:16:34Z Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations Gregory C.; Rino G.; Richard G.; Ghazinyan H.; Dokmeci K.; Tatsuo K.; JIA-HORNG KAO; George L.; Laurentius L.; Ismail M.; Masao O.; Diana P.; Teerha P.; Sarin S.K.; Manoj S.; Jose S.; Simone S.; Tawesak T.; Jafri W.; Lai W.; Mo Y.J.; Osamu Y.; Lau G.; Sharma M.; APASL Covid-19 Task Force
臺大學術典藏 2021-09-04T05:16:33Z Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Hepatitis B reactivation: diagnosis and management Huang S.-C.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:33Z Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data Hong C.-M.; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; JIA-HORNG KAO; Liu C.-J.
臺大學術典藏 2021-09-04T05:16:32Z Towards elimination of viral hepatitis in Taiwan by 2025: In memory of Professor Ding-Shinn Chen (1943–2020) Yang H.-C.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:31Z Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes Hsu C.-S.; Liu W.-L.; Li Q.; Lowey B.; Hertz L.; Chao Y.-C.; Liang T.J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:31Z Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH) Huang C.-F.; Lai H.-C.; Chen C.-Y.; Tseng K.-C.; Kuo H.-T.; Hung C.-H.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; Tai C.-M.; Lin C.-W.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Chuang W.-L.; Tsai P.-C.; Peng C.-Y.; Yu M.-L.
臺大學術典藏 2021-09-04T05:16:31Z HIGHLIGHTS JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:30Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:30Z Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients Yeo Y.H.; Tseng T.-C.; Hosaka T.; Cunningham C.; Fung J.Y.Y.; Ho H.J.; Kwak M.-S.; Trinh H.N.; Ungtrakul T.; Yu M.-L.; Kobayashi M.; Le A.K.; Henry L.; Li J.; Zhang J.; Sriprayoon T.; Jeong D.; Tanwandee T.; Gane E.; Cheung R.C.; Wu C.-Y.; Lok A.S.; Lee H.-S.; Suzuki F.; Yuen M.-F.; JIA-HORNG KAO; Yang H.-I.; Nguyen M.H.
臺大學術典藏 2021-09-04T05:16:30Z Progress towards elimination goals for viral hepatitis Cox A.L.; El-Sayed M.H.; JIA-HORNG KAO; Lazarus J.V.; Lemoine M.; Lok A.S.; Zoulim F.
臺大學術典藏 2021-09-04T05:16:29Z Highlights JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:29Z Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy Lin C.-L.; Tseng K.-C.; Chen K.-Y.; Liao L.-Y.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:29Z Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan Su H.-J.; JIA-HORNG KAO; Tseng T.-C.; Yang H.-C.; Su T.-H.; Chen P.-J.; Liu C.-J.
臺大學術典藏 2021-09-04T05:16:28Z Relationship between serum gamma-glutamyl transferase level and colorectal adenoma Hong T.-C.; Yang H.-C.; Chen C.-L.; JIA-HORNG KAO; Liu C.-J.; Chen M.-J.; Wang H.-Y.; Kuo Y.-C.; Yu L.-Y.; Hu K.-C.
臺大學術典藏 2021-09-04T05:16:28Z Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH) Tsai P.-C.; Chen C.-Y.; Kuo H.-T.; Hung C.-H.; Tseng K.-C.; Lai H.-C.; Peng C.-Y.; Wang J.-H.; Chen J.-J.; Lee P.-L.; Chien R.-N.; Yang C.-C.; Lo G.-H.; JIA-HORNG KAO; Liu C.-J.; Liu C.-H.; Yan S.-L.; Bair M.-J.; Lin C.-Y.; Su W.-W.; Chu C.-H.; Chen C.-J.; Tung S.-Y.; Tai C.-M.; Lin C.-W.; Lo C.-C.; Cheng P.-N.; Chiu Y.-C.; Wang C.-C.; Cheng J.-S.; Tsai W.-L.; Lin H.-C.; Huang Y.-H.; Yeh M.-L.; Huang C.-F.; Hsieh M.-H.; Huang J.-F.; Dai C.-Y.; Chung W.-L.; Ke C.-L.K.; Yu M.-L.; T-COACH Study Group

Showing items 656-680 of 1180  (48 Page(s) Totally)
<< < 22 23 24 25 26 27 28 29 30 31 > >>
View [10|25|50] records per page